NCT03333603View on ClinicalTrials.gov

Pharmacokinetics and Safety Studies of Esomeprazole Use in Schizophrenia Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 23, 2016

Primary Completion Date

January 23, 2017

Study Completion Date

January 23, 2017

Conditions
Schizophrenia
Interventions
DRUG

esomeprazole

esomeprazole 40mg /tab oral Day1-Day14 then 40mg/2 tab oral Day15-Day56

Trial Locations (2)

10048

National Taiwan University Hospital, Taipei

Unknown

National Taiwan University Hospital Yunlin Branch, Taipei

All Listed Sponsors
collaborator

National Taiwan University

OTHER

lead

National Taiwan University Hospital

OTHER

NCT03333603 - Pharmacokinetics and Safety Studies of Esomeprazole Use in Schizophrenia Patients | Biotech Hunter | Biotech Hunter